Tekrardan Hoşgeldiniz
Cointime’a Katıl
Giriş Yap
Kayıt Ol
Gelen kutunuzu kontrol edin
RMI Partners
About
RMI Partners is VC firm focused on breakthrough developments of pharmaceutical products and technologies based in the U.S. and Russia.
- 11 - 50
Highlights
Details
- Industries
- Biotechnology,Life Science,Venture Capital
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
RMI Partners is a venture company established in 2012, with a strategic focus on investments supporting the development of innovative biopharmaceutical products and medical technologies. In Eastern Europe and Russia, RMI Partners is one of the largest investors in life sciences. The company makes global investments in a variety of therapeutic areas.
RMI Partners is currently managing the venture fund RusnanoMedInvest (RMI, a subsidiary of JSC RUSNANO), which was created in 2012 to develop innovative projects in the field of medicine and pharmaceutics. RMI’s portfolio includes companies from Russia, USA, UK and Israel, specializing in the development and marketing of innovative pharmaceutical and medical technologies, many of which successfully completed an initial public offering (IPO) on NASDAQ, or were purchased by strategic buyers.
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 5, 2015
Transcend Medical
|
Series Unknown | $7.20M | Health Care | — |
|
Oct 6, 2014
Miramar Labs
|
Series D | $26M | Health Care | — |
|
Apr 2, 2014
Transcend Medical
|
Series C | $29M | Health Care | — |
|
Dec 19, 2012
Marinus Pharmaceuticals
|
Series Unknown | $11.43M | Biopharma | — |
